Actively Recruiting
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
Led by Shanghai Chest Hospital · Updated on 2025-07-11
250
Participants Needed
1
Research Sites
29 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Exploring the Clinical Application Value of Contrast Enhancement Features in CE-EBUS Images for the Diagnosis of Pulmonary Lesions and Intrapulmonary Lymph Nodes
CONDITIONS
Official Title
A Study of Contrast-enhanced EBUS in Lung Lesions and Intrathoracic Lymph Nodes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Enlargement of at least one intrathoracic lymph node with short diameter over 1 cm or central lung lesions near the airway detected by chest CT, or increased fluorodeoxyglucose uptake on PET/CT (SUV > 2.5)
- Need for CP-EBUS-TBNA for diagnosis or staging and agreement to undergo CE-EBUS with no contraindications
- Good compliance and signed informed consent
You will not qualify if you...
- Known hypersensitivity to ultrasound contrast components
- Severe pulmonary hypertension (pulmonary artery pressure over 90 mmHg)
- Angina pectoris, acute coronary syndrome, unstable ischemic heart disease, heart failure, cardiac dysfunction, or cardiac disease with right-to-left shunting
- Uncontrolled essential hypertension or respiratory distress syndrome
- Pregnancy or lactation
- Contraindications to bronchoscopy
- Other conditions making participation unsuitable as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
J
Jiayuan sun
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here